DIO1 and kidney cancer: Low expression of DIO1 is associated with poor prognosis of kidney cancer, restoration of its expression or targeted therapy is a potential strategy, and selenium supplementation needs to be evaluated individually (Arnaldi et al. 2005; Zhao et al. 2022; Poplawski et al. 2017)